Global FHIR ePI IG ToC
	1. Purpose
	2. General Technical Conformance Requirements
		a. Identifiers, IDs, and Codes 
		b. Date and time
		c. Tracking content changes
		d. Acceptable file types
		e. File naming
		f. External file references
		g. Case sensitivity
		h. Display name
		i. Image quality
		j. Text
		k. Section headings
		l. Accessibility
		m. Semi-structured Text
		n. Text formatting and style
			i. Recent Major Changes
			ii. Bold, Italics, Underline
			iii. Symbols and special characters
			iv. Superscript and subscript
			v. Hypertext links and cross-referencing
			vi. Table formatting
			vii. Lists
			viii. Images
		o. Derived Content
	3. Global Profile
		a. List
		b. Bundle
		c. Composition
		d. Organization
		e. Regulated Authorization
		f. Medicinal Product Definition
		g. Administrable Product Definition
		h. Manufactured Item Definition
		i. Ingredient
		j. Packaged Product Definition
		k. Clinical Use Definition
			i. Clinical Use Definition Contraindication
			ii. Clinical Use Definition Indication
			iii. Clinical Use Definition Interaction
			iv. Clinical Use Definition Undesirable Effect
			v. Clinical Use Definition Warning
		l. Substance Definition
		m. Binary
		n. Signature
	4. Appendix
		a. Glossary
		b. Global Code systems

Annex I - EU/EMA FHIR ePI Profile
	1. EMA Profile
		a. List
		b. Bundle
		c. Composition
		d. List
		e. Binary
	2. Appendix
		a. Glossary
		b. Code systems

Annex II - US/FDA FHIR ePI Profile
	1. FDA Profile
	2. Appendix
		a. Glossary
		b. Code systems

Annex III - Japan/PMDA FHIR ePI Profile
	1. PMDA Profile
	2. Appendix
		a. Glossary
    b. Code systems
